What is the Success Rate of Pazopanib?

Pazopanib is an anticancer medication which is used for the treatment of kidney cancer. It is available as 200mg or 400mg tablet. Paznib is the brand name of this medication and it is a part of the target therapy medication. These tablets are the tyrosine kinase inhibitor which inhibits the VEGF (vascular endothelial growth factor receptors). These receptors are a part of angiogenesis which helps in the formation of blood vessels which help nourish the cancer cells. Pazopanib also has antineoplastic properties which stops the growth of the cancer cells and also kills them or shrinks their size. Pazopanib tablets 400 mg are taken once every day one or two hour before the meal.

Some of the precautions to remember before taking Pazopanib tablets are such as –

·         It is highly possible that you are allergic to any of the component of the tablet hence, gather complete information about Pazopanib before starting the use.

·         Inform the doctor if you had bleeding in the stomach or surgery in the last six months.

·         Pazopanib can harm the fetus hence, it is advisable to avoid pregnancy and breast feeding during the treatment.

·         Inform the doctor if you have any thyroid disease or any heart issue such as high blood pressure, irregular heart rate or prolonged QT interval.

·         Pazopanib can interact with medications such as – antibiotics like clarithromycin, antiviral or antifungal medications, and seizure medications such as carbamazepine.

Some of the main side effects of Pazopanib are such as –

·         Swelling in the face

·         Weakness

·         Hair loss

·         Brittle hair and nails

·         Constipation and also vomiting

·         Weight loss

·         Skin lightening in certain areas

·         Irregular heart rate

·         Blood in the stool

·         Coughing up blood

·         Wounds that take time to heal

·         Stomach swelling

·         Dizziness

Success rate of Pazopanib –

Pazopanib shows potential in soft tissue sarcoma as it the 86% of the patients showed progress and 13% of the patients remained stable where the disease did not progress. For renal cell carcinoma too, the Pazopanib tablets showed favourable results. 27 months was the median survival rate for the patients who take Pazopanib in comparison to 26 months for people who received Sunitinib.

Pazopanib is a very effective and a safe medication. Pazopanib 200 mg price is quite high so, it can be purchased using Magicine Pharma. This medication is manufactured by Arechar Healthcare and is provided by Magicine Pharma which offers various discounts with their medicines.